Officials Show Little Proof That New Tech Will Help Medicaid Enrollees Meet Work Rules
The Trump administration says it’s developing a digital tool to help people prove they’re meeting new Medicaid work requirements. KFF Health News talked to officials from the two states running pilot programs and found little evidence of new — or effective — technology.
A New Car vs. Health Insurance? Average Family Job-Based Coverage Hits $27K
KFF data shows that 2025 marked the first time in two decades that the annual cost of covering a family of four rose by 6% or more for three consecutive years.
Despite the Hoopla, Vaccines Should Be in Reach This Cough-and-Cold Season
Recommendations surrounding covid vaccinations and other such shots have been confusing. Ultimately, though, little has changed. Here’s what you need to know.
‘Cancer Doesn’t Care’: Citizen Lobbyists Unite To Push Past Washington’s Ugly Politics
Despite a poisonous political climate, hundreds of volunteer advocates put partisan differences aside and pressed Congress to help people with cancer.
Private Medicare, Medicaid Plans Exaggerate In-Network Mental Health Options, Watchdogs Say
A federal probe of Medicare and Medicaid plans run by private insurance companies found that the plan operators often overstated how many mental health providers were available in their networks. In some cases, investigators found providers had never had contracts with plans they were listed on.
‘Chemtrail’ Theories Warn of Health Dangers From Contrails. The Idea Takes Wing at Kennedy’s HHS.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Luego de criticar a demócratas por su política transgénero, Newsom veta una medida de salud clave
La ley habría obligado a las aseguradoras a cubrir y a las farmacéuticas a dispensar 12 meses de terapia hormonal de una sola vez a pacientes transgénero y a otras personas.
After Chiding Democrats on Transgender Politics, Newsom Vetoes a Key Health Measure
California Gov. Gavin Newsom vetoed a bill that would have expanded access to hormone therapy, a top priority for the trans community. Advocates say it would have ensured continuity in gender-affirming care amid Trump administration attacks. Analysts say it’s another sign of the Democrat’s move to the center.
